$1.8M Bet On This Health Care Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones index closed lower by around 0.2% on Thursday. When insiders purchase or sell shares, it…
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers Sharps Technology (NASDAQ:STSS) shares rose 50.5% to $0.32 during Friday’s after-market session. The market value of their…
Aclaris Therapeutics’ ATI-1777 Faces Uphill Battle In Atopic Dermatitis Treatment Landscape, Analyst Downgrades
HC Wainwright downgrades Aclaris Therapeutics post Phase 2b results of ATI-1777 for atopic dermatitis. Analyzing efficacy, commercial prospects, and competitive landscape.
Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Shares of CommScope Holding Company, Inc. (NASDAQ: COMM) fell sharply during Monday’s session.
B of A Securities analyst Tal Liani downgraded CommScope from Neutral to Underperform and lowered the price target from $2.1 to $2.
CommScope shares dipped 6.9% to $2.2150 on Monday.
Why Coherus BioSciences Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
Shares of Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose sharply in today’s pre-market trading after the company announced an agreement to divest ophthalmology franchise to Sandoz in $170 million upfront all cash deal.
12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers Vaxart (NASDAQ:VXRT) shares rose 37.5% to $0.77 during Tuesday’s regular session. The company’s market cap stands at…
Why Is Dermatology Focused Aclaris Therapeutics Stock Trading Higher Today?
Aclaris Therapeutics leadership changes and strategic review. Preliminary unaudited data as of Dec 31, 2023, reveals approximately $182M in cash, cash equivalents, and marketable securities. Aclaris reiterates business plans for ongoing programs.
The Analyst Landscape: 4 Takes On Aclaris Therapeutics
In the last three months, 4 analysts have published ratings on Aclaris Therapeutics (NASDAQ:ACRS), offering a diverse range…
Analyst Highlights Aclaris Therapeutics’ Encouraging Efficacy For Eczema Candidate, But Cautions On Data Variations
Wednesday, Aclaris Therapeutics Inc (NASDAQ: ACRS) released topline results from its Phase 2b study of ATI-1777, an investigational topical "soft" JAK 1/3 inhibitor, in patients with mild to
Crude Oil Falls 1%; Amarin Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 100 points on Wednesday.
The Dow traded up 0.29% to 37,633.43 while the NASDAQ rose 0.72% to 14,965.31. The S&P 500 also rose, gaining, 0.48% to 4,779.31.